Found: 7
Select item for more details and to access through your institution.
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35378-z
- By:
- Publication type:
- Article
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article
The imprinted Zdbf2 gene finely tunes control of feeding and growth in neonates.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.65641
- By:
- Publication type:
- Article
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.781833
- By:
- Publication type:
- Article
Cylindroma of the breast with CYLD gene mutation: a case report and review of the literature.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 8, p. 7133, doi. 10.1007/s11033-023-08606-y
- By:
- Publication type:
- Article
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article